SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-08
👔
KAZIA THERAPEUTICS LTD
@KZIA_InsiderForm 4 Filing: Bonacorda Jeffrey Acquires (Grant) shares of $KZIA
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
KAZIA THERAPEUTICS LTD
Ticker: $KZIA
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-01-08
Shares: 150,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Bonacorda Jeffrey, holds the title of VP, Finance and Controller at KAZIA THERAPEUTICS LTD.
On 2026-01-08, the insider transacted 150,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Bonacorda Jeffrey (VP, Finance and Controller) was granted $0 of $KZIA
Post-Transaction Position: 150,000 shares
SEC Accession No: 0001213900-26-076429 (CIK: 2115111)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.